- Wright Medical Group (NASDAQ:WMGI) upgraded to Buy with a $30 (12% upside) price target at Needham citing upside from Cartiva acquisition. Shares down 3% premarket on equity offering to finance the transaction.
- Fresenius Medical Care (NYSE:FMS) upgraded to Buy with a €107 (59% upside) price target at HSBC Securities. Shares up 1% premarket.
- Affimed Therapeutics (NASDAQ:AFMD) upgraded to Buy with a $4 (premarket price above this) price target at Jefferies on drug development deal with Genentech. Shares up 169% premarket.